Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Topotecan in Treating Children With Refractory Leukemia

ClinicalTrials.gov ID: NCT00002705

Public ClinicalTrials.gov record NCT00002705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

TOPOTECAN FOR CHILDREN WITH REFRACTORY LEUKEMIA, A PEDIATRIC ONCOLOGY GROUP PHASE I COOPERATIVE AGREEMENT STUDY

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase I trial to study the effectiveness of topotecan in treating children with refractory leukemia. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.

Study identification

NCT ID
NCT00002705
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
3 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1996 (Type not available)
Primary completion
Jan 2001 (Actual)
Completion
Not listed
Last update posted
Feb 1, 2013

Started 1996

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
University of California San Diego Cancer Center La Jolla California 92093-0658 —
Lucile Packard Children's Hospital at Stanford Palo Alto California 94304 —
Shands Hospital and Clinics, University of Florida Gainesville Florida 32610-100277 —
Emory University Hospital - Atlanta Atlanta Georgia 30322 —
Children's Memorial Hospital, Chicago Chicago Illinois 60614 —
University of Kansas Medical Center Kansas City Kansas 66160-7357 —
Via Christi Regional Medical Center Wichita Kansas 67214 —
MBCCOP - LSU Medical Center New Orleans Louisiana 70112 —
Johns Hopkins Oncology Center Baltimore Maryland 21287 —
Boston Floating Hospital Infants and Children Boston Massachusetts 02111 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Children's Hospital of Michigan Detroit Michigan 48201 —
Washington University School of Medicine St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
State University of New York - Upstate Medical University Syracuse New York 13210 —
Memorial Mission Hospital Asheville North Carolina 28801 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Saint Jude Children's Research Hospital Memphis Tennessee 38105-2794 —
Medical City Dallas Hospital Dallas Texas 75230 —
Simmons Cancer Center - Dallas Dallas Texas 75235-9154 —
Baylor College of Medicine Houston Texas 77030 —
San Antonio Military Pediatric Cancer and Blood Disorders Center Lackland Air Force Base Texas 78236-5300 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78284-7811 —
Midwest Children's Cancer Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00002705 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →